Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.64 |
| ▸ | GAA | P10253 | 8/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.64 |
| ▸ | ALOX12 | P18054 | 7/20 | 0.64 |
| ▸ | GFER | P55789 | 5/20 | 0.64 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.64 |
| ▸ | SYK | P43405 | 1/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | HTT | P42858 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.52 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.52 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17009127 | 0.93 | MAPT (0.61) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010322 | 0.91 | MAPT (0.59) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010288 | 0.91 | GFER (0.68) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010276 | 0.90 | GFER (0.54) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010292 | 0.90 | GFER (0.54) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010260 | 0.89 | MAPT (0.54) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010305 | 0.89 | GFER (0.52) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010258 | 0.88 | GFER (0.50) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010319 | 0.88 | ENPP2 (0.59) | MAPTGAAALOX15ALOX12GFER | |
| SCHEMBL19010324 | 0.87 | MAPT (0.47) | MAPTGAAALOX15ALOX12GFER |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9834548-B2 | Pyridazine compounds as JAK inhibitors | PORTOLA PHARMACEUTICALS, INC. (US) | 2017-12-05 | — | — | US | disclosed |
| US-20170174673-A1 | PYRIDAZINE COMPOUNDS AS JAK INHIBITORS | ALEXION PHARMACEUTICALS, INC. | 2017-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174673-A1 | PYRIDAZINE COMPOUNDS AS JAK INHIBITORS | JAK1, JAK2, JAK3 | MAPT 53/4885GAA 2694/4885ALOX15 1252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.